VKTX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Viking Therapeutics, Inc. Shareholders Who Lost Money
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Viking Therapeutics, Inc. for potential violations of federal securities laws. This follows a 9% stock price increase after positive trial data for their anti-obesity drug VK2735 was released.
November 14, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Viking Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations. This comes after a 9% stock price increase due to positive trial data for their drug VK2735.
The investigation by Levi & Korsinsky could lead to legal challenges or penalties for Viking Therapeutics, potentially impacting investor confidence negatively. Despite the recent stock price increase due to positive drug trial data, the legal probe introduces uncertainty, likely causing short-term downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100